Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Colorectal Cancer

Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy
Randomized, Active-Controlled, Open-Label Phase 2 Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy
Status: Archived
Georgia Cancer Specialists
mi
from
Atlanta, GA
Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy
Randomized, Active-Controlled, Open-Label Phase 2 Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy
Status: Archived
Updated: 1/1/1970
Georgia Cancer Specialists
mi
from
Atlanta, GA
Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy
Randomized, Active-Controlled, Open-Label Phase 2 Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy
Status: Archived
Victor Priego
mi
from
Bethesda, MD
Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy
Randomized, Active-Controlled, Open-Label Phase 2 Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy
Status: Archived
Updated: 1/1/1970
Victor Priego
mi
from
Bethesda, MD
Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy
Randomized, Active-Controlled, Open-Label Phase 2 Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy
Status: Archived
Gabrail Cancer Center Research LLC
mi
from
Canton, OH
Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy
Randomized, Active-Controlled, Open-Label Phase 2 Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy
Status: Archived
Updated: 1/1/1970
Gabrail Cancer Center Research LLC
mi
from
Canton, OH
Selective Internal Radiation Therapy (SIRT) in Patients With Unresectable Colorectal Cancer Liver Metastases Who Failed Prior Intraarterial Pump Chemotherapy
Phase I Study of Selective Internal Radiation Therapy (SIRT) in Patients With Unresectable Colorectal Cancer Liver Metastases Who Failed Prior Intraarterial Pump Chemotherapy
Status: Archived
Memorial Sloan-Kettering Cancer Center 1275 York Avenue
mi
from
New York, NY
Selective Internal Radiation Therapy (SIRT) in Patients With Unresectable Colorectal Cancer Liver Metastases Who Failed Prior Intraarterial Pump Chemotherapy
Phase I Study of Selective Internal Radiation Therapy (SIRT) in Patients With Unresectable Colorectal Cancer Liver Metastases Who Failed Prior Intraarterial Pump Chemotherapy
Status: Archived
Updated: 1/1/1970
Memorial Sloan-Kettering Cancer Center 1275 York Avenue
mi
from
New York, NY
The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function
The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function
Status: Archived
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function
The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function
Status: Archived
Updated: 1/1/1970
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Figitumumab Combined With Pegvisomant For Advanced Solid Tumors
Phase 1 Safety And Tolerability Study Of Figitumumab Combined With Pegvisomant In Patients With Advanced Solid Tumors
Status: Archived
Pfizer Investigational Site
mi
from
Duluth, MN
Figitumumab Combined With Pegvisomant For Advanced Solid Tumors
Phase 1 Safety And Tolerability Study Of Figitumumab Combined With Pegvisomant In Patients With Advanced Solid Tumors
Status: Archived
Updated: 1/1/1970
Pfizer Investigational Site
mi
from
Duluth, MN
Genetic Investigation of Solid Tumors Cohort
Genetic Investigation of Solid Tumors Cohort
Status: Archived
Scripps HealthCare
mi
from
LaJolla, CA
Genetic Investigation of Solid Tumors Cohort
Genetic Investigation of Solid Tumors Cohort
Status: Archived
Updated: 1/1/1970
Scripps HealthCare
mi
from
LaJolla, CA
A Comparison of Methods to Detect Polyps During Colonoscopy
Comparison of Detection of Polyps During Both Insertion and Withdrawal Phases of Colonoscopy Versus the Standard Practice of Detection of Polyps During the Withdrawal Phase of Colonoscopy: A Prospective Quality Improvement Study
Status: Archived
Cleveland Clinic Florida
mi
from
Weston, FL
A Comparison of Methods to Detect Polyps During Colonoscopy
Comparison of Detection of Polyps During Both Insertion and Withdrawal Phases of Colonoscopy Versus the Standard Practice of Detection of Polyps During the Withdrawal Phase of Colonoscopy: A Prospective Quality Improvement Study
Status: Archived
Updated: 1/1/1970
Cleveland Clinic Florida
mi
from
Weston, FL
Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients
A Phase IA, Multicenter, Open-label Dose Escalation Study of BKM120, Administered Orally in Adult Patients With Advanced Solid Malignancies
Status: Archived
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients
A Phase IA, Multicenter, Open-label Dose Escalation Study of BKM120, Administered Orally in Adult Patients With Advanced Solid Malignancies
Status: Archived
Updated: 1/1/1970
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients
A Phase IA, Multicenter, Open-label Dose Escalation Study of BKM120, Administered Orally in Adult Patients With Advanced Solid Malignancies
Status: Archived
Sarah Cannon Cancer Center
mi
from
Nashville, TN
Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients
A Phase IA, Multicenter, Open-label Dose Escalation Study of BKM120, Administered Orally in Adult Patients With Advanced Solid Malignancies
Status: Archived
Updated: 1/1/1970
Sarah Cannon Cancer Center
mi
from
Nashville, TN
A Dose Ranging Study of Delayed Release Beclomethasone for Prevention of Acute Enteritis in Patients With Rectal Cancer
A Phase 1/2 Study to Evaluate Escalating Doses of DOR201 [Enteric-Coated Oral Beclomethasone Dipropionate (BDP)] for Prevention of Signs and Symptoms of Acute Enteritis in Patients With Rectal Cancer Treated With Combined Chemotherapy and Radiation Therapy
Status: Archived
Northwestern University
mi
from
Chicago, IL
A Dose Ranging Study of Delayed Release Beclomethasone for Prevention of Acute Enteritis in Patients With Rectal Cancer
A Phase 1/2 Study to Evaluate Escalating Doses of DOR201 [Enteric-Coated Oral Beclomethasone Dipropionate (BDP)] for Prevention of Signs and Symptoms of Acute Enteritis in Patients With Rectal Cancer Treated With Combined Chemotherapy and Radiation Therapy
Status: Archived
Updated: 1/1/1970
Northwestern University
mi
from
Chicago, IL
A Dose Ranging Study of Delayed Release Beclomethasone for Prevention of Acute Enteritis in Patients With Rectal Cancer
A Phase 1/2 Study to Evaluate Escalating Doses of DOR201 [Enteric-Coated Oral Beclomethasone Dipropionate (BDP)] for Prevention of Signs and Symptoms of Acute Enteritis in Patients With Rectal Cancer Treated With Combined Chemotherapy and Radiation Therapy
Status: Archived
Boston Med Center
mi
from
Boston, MA
A Dose Ranging Study of Delayed Release Beclomethasone for Prevention of Acute Enteritis in Patients With Rectal Cancer
A Phase 1/2 Study to Evaluate Escalating Doses of DOR201 [Enteric-Coated Oral Beclomethasone Dipropionate (BDP)] for Prevention of Signs and Symptoms of Acute Enteritis in Patients With Rectal Cancer Treated With Combined Chemotherapy and Radiation Therapy
Status: Archived
Updated: 1/1/1970
Boston Med Center
mi
from
Boston, MA
Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors
A Pilot, Phase II , Open Label, Nonrandomized, Multi- Center Study of [F 18]HX4 Positron Emission Tomography (PET) to Detect Hypoxia in Tumors
Status: Archived
Holy Name Medical Center
mi
from
Teaneck, NJ
Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors
A Pilot, Phase II , Open Label, Nonrandomized, Multi- Center Study of [F 18]HX4 Positron Emission Tomography (PET) to Detect Hypoxia in Tumors
Status: Archived
Updated: 1/1/1970
Holy Name Medical Center
mi
from
Teaneck, NJ
AVASTART - Observational Study of Bevacizumab [Avastin] in Patients With Metastatic Colorectal Cancer
Status: Archived
Trial Information Support Line
mi
from
South San Francisco, CA
AVASTART - Observational Study of Bevacizumab [Avastin] in Patients With Metastatic Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Trial Information Support Line
mi
from
South San Francisco, CA
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
Status: Archived
University of California, Davis Department of Dermatology
mi
from
Sacramento, CA
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
Status: Archived
Updated: 1/1/1970
University of California, Davis Department of Dermatology
mi
from
Sacramento, CA
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
Status: Archived
Los Angeles County-USC Medical Center
mi
from
Los Angeles, CA
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
Status: Archived
Updated: 1/1/1970
Los Angeles County-USC Medical Center
mi
from
Los Angeles, CA
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
Status: Archived
The Florida Hospital
mi
from
Orlando, FL
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
Status: Archived
Updated: 1/1/1970
The Florida Hospital
mi
from
Orlando, FL
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
Status: Archived
Southern Regional Medical Center
mi
from
Riverdale, GA
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
Status: Archived
Updated: 1/1/1970
Southern Regional Medical Center
mi
from
Riverdale, GA
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
Status: Archived
North Shore University Health Systems
mi
from
Evanston, IL
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
Status: Archived
Updated: 1/1/1970
North Shore University Health Systems
mi
from
Evanston, IL
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
Status: Archived
Lester E. Cox Medical Center
mi
from
Springfield, MO
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
Status: Archived
Updated: 1/1/1970
Lester E. Cox Medical Center
mi
from
Springfield, MO
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
Status: Archived
St. Louis Hematology Oncology Specialists, Inc.
mi
from
St. Louis, MO
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
COMPRES - COMpression Anastomosis Ring (CARâ„¢ 27/ColonRingâ„¢) Post maRketing Evaluation Study
Status: Archived
Updated: 1/1/1970
St. Louis Hematology Oncology Specialists, Inc.
mi
from
St. Louis, MO
Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal Metastases
Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal Metastases
Status: Archived
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal Metastases
Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal Metastases
Status: Archived
Updated: 1/1/1970
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor
A Prospective Clinical Trial Evaluating Potential Biomarkers for Bevacizumab Induced Hypertension
Status: Archived
Vanderbilt-Ingram Cancer Center - Cool Springs
mi
from
Franklin, TN
Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor
A Prospective Clinical Trial Evaluating Potential Biomarkers for Bevacizumab Induced Hypertension
Status: Archived
Updated: 1/1/1970
Vanderbilt-Ingram Cancer Center - Cool Springs
mi
from
Franklin, TN
Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor
A Prospective Clinical Trial Evaluating Potential Biomarkers for Bevacizumab Induced Hypertension
Status: Archived
Vanderiblt University Medical Center
mi
from
Nashville, TN
Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor
A Prospective Clinical Trial Evaluating Potential Biomarkers for Bevacizumab Induced Hypertension
Status: Archived
Updated: 1/1/1970
Vanderiblt University Medical Center
mi
from
Nashville, TN
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Yale University School of Medicine
mi
from
New Haven, CT
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Yale University School of Medicine
mi
from
New Haven, CT
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Hematology Oncology Associates of Northern NJ
mi
from
Morristown, NJ
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Hematology Oncology Associates of Northern NJ
mi
from
Morristown, NJ
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
New Haven, CT
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
New Haven, CT
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Keryx / AOI Investigative Site
mi
from
Fort Myers, FL
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Keryx / AOI Investigative Site
mi
from
Fort Myers, FL
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Hollywood, FL
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Hollywood, FL
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Athens, GA
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Athens, GA
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Keryx / AOI Investigative Site
mi
from
Lawrenceville, GA
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Keryx / AOI Investigative Site
mi
from
Lawrenceville, GA
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Niles, IL
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Niles, IL
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Indianapolis, IN
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Indianapolis, IN
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Baltimore, MD
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Baltimore, MD
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Lansing, MI
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Lansing, MI
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Jackson, MS
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Jackson, MS
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Raleigh Regional Cancer Center
mi
from
Beckley, WV
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Raleigh Regional Cancer Center
mi
from
Beckley, WV
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Lincoln, NE
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Lincoln, NE
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Henderson, NV
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Henderson, NV
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Albuquerque, NM
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Albuquerque, NM
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
South Carolina Oncology Associates, PA
mi
from
Columbia, SC
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
South Carolina Oncology Associates, PA
mi
from
Columbia, SC
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Charlotte, NC
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Charlotte, NC
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Fargo, ND
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Fargo, ND
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Cincinnati, OH
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Cincinnati, OH
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Oklahoma City, OK
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Oklahoma City, OK
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Columbia, SC
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Columbia, SC
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Kingsport, TN
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Kingsport, TN
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Tennessee Oncology
mi
from
Nashville, TN
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Tennessee Oncology
mi
from
Nashville, TN
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Bedford, TX
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Bedford, TX
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Roanoke, VA
Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Status: Archived
Updated: 1/1/1970
Keryx / AOI Pharmaceuticals Investigative Site
mi
from
Roanoke, VA